secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2022-05-25T23:59:59+00:00
Accession:  0000914475-22-000032
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine Biosciences repurchases $179.4M of convertible notes, reduces debt by ~60% over two years
--------------------------------------------------------------------------------

- Repurchased $179.4M principal of 2.25% Convertible Senior Notes due 2024 for ~$224M cash plus stock-price-based component and accrued interest.
- After repurchase, $201.8M principal remains outstanding; reduced from initial $517.5M.
- CFO states debt reduction of ~60% over two years aims to minimize shareholder dilution.
- Repurchases expected to close by June 14, 2022 under separate private agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447522000032/0000914475-22-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447522000032/nbix-20220524.htm
  HTML page:      https://secwatch.observer/filing/0000914475-22-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer